Cancers

Neoplastic disorders

This page about the cancers category of medicines automatically lists related information collected from other pages of our website.

The Cancers category of medicines is also known as neoplastic disorders.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - cancers

Audience:
       

11 Mar 2016 Tumour markers can be helpful in diagnosing, monitoring and treating cancer. Find out more about tumour biomarkers here.
For health professionals
01 Mar 2016 Find out which tests, treatments or procedures healthcare providers and consumers should question, as recommended by Australian medical colleges.
(Medical test)
12 May 2015 X-rays and contrast X-rays have benefits and risks: find out what these are
22 Apr 2015
Recommendations from The Royal College of Pathologists of Australasia about urinary tract infections, PSA testing, vitamin D deficiency screening, serum tumor marker tests and hyperlipidaemia.
(Medicine)
09 Feb 2015 Find out about Oxaliplatin MYX Concentrate for injection. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
09 Feb 2015 Find out about Irinotecan MYX Concentrate for infusion. Plus information and tips on how to use medicines wisely and safely.
(Medicine)
09 Feb 2015 Find out about Letrozole FBM Tablets. Plus information and tips on how to use medicines wisely and safely.
(Consumer publication)
05 Nov 2013 Targeted anticancer therapies recognise features of a cancer cell that make it different to normal cells in the body. Being more specific means these therapies can damage cancer cells as effectively as traditional chemotherapy, but with different and often less severe side effects.
(Media release)
01 Aug 2013 The August edition of Australian Prescriber is out now and covers Clostridium difficile infection, the growing threat of antibiotic resistance and targeted anti-cancer therapies
(Media release)
01 Aug 2013 Over the past ten years, several new classes of targeted anti-cancer therapies have made their way into mainstream therapy for cancer.

Subcategories of cancers